Biosense Webster launches Thermocool SF irrigated ablation catheter in the EU

14 May 2010

Biosense Webster, Inc. has announced the completion of the first clinical cases with the new Thermocool SF Irrigated Ablation catheter in the EU, following recent CE Mark approval.

The catheter is the most advanced Biosense Webster irrigated ablation catheter for use by electrophysiologists in treating cardiac arrhythmias, commonly referred to as irregular heart rhythms.

The catheter is a 'next generation' irrigated ablation catheter and builds upon the Thermocool irrigated catheter platform. Its unique design and porous tip technology provides electrophysiologists with uniform cooling across the entire catheter tip and allows efficient cooling at half the flow rate.

"The Thermocool SF Irrigated Catheter is the latest advancement in irrigated ablation catheter design with its groundbreaking and unique porous tip technology," said Shlomi Nachman, Worldwide President, Biosense Webster, Inc. "This innovation further builds upon our clear leadership position in the electrophysiology market and reinforces our long-standing commitment to electrophysiologists and their patients. "We are extremely pleased this exciting new product will be launched throughout the European Union over the coming months."

Prof. Gerd Hindricks of the Heart Center at the University of Leipzig Hospital commented: "The Thermocool SF catheter is a new and exciting technology that represents a significant advancement in irrigated ablation for electrophysiologists.

"My first clinical experience indicates that due to the strategic placement of the holes around the entire surface area of the tip, cooling efficiency and lesion induction may be improved to complete Atrial Fibrillation ablation procedures in a safe, effective, and timely manner."

"Procedure time & safety concerns are consistently cited by EPs as the most significant barrier to increased use of ablation therapy to treat cardiac arrhythmias," added Nachman. "All of our products are being developed with the aim of addressing these concerns."

The ThermoCool SF(R) catheter is the latest in a series of innovations from Biosense Webster. In recent months, the company has launched its ground-breaking new 3D mapping platform, the CARTO 3 System in Europe and the NAVISTAR & Celsius RMT Thermocool Catheters globally.

To top